Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore;Se préparer pour la pandémie de COVID-19: revue des moyens déployés dans un bloc opératoire d’un grand hôpital tertiaire au Singapour

Canadian Journal of Anesthesia

Volumn 67, Issue 6, 2020, Pages 732-745

  Wong, Jolin ^a   Goh, Qing Yuan ^a   Tan, Zihui ^a   Lie, Sui An ^a   Tay, Yoong Chuan ^a   Ng, Shin Yi ^a   Soh, Chai Rick ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CORONAVIRUS DISEASE 2019; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HOSPITAL EMERGENCY SERVICE; HUMAN; INFECTION CONTROL; ISOLATION FACILITY; MEDICAL STAFF; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SINGAPORE; TERTIARY CARE CENTER; WORKFLOW; CORONAVIRUS INFECTION; EPIDEMIC; OPERATING ROOM; PREVENTION AND CONTROL; VIRUS PNEUMONIA;

CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFECTION CONTROL; OPERATING ROOMS; PANDEMICS; PNEUMONIA, VIRAL; SINGAPORE; TERTIARY CARE CENTERS;

EID: 85081896575     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-020-01620-9     Document Type: Review

References (72)

1. World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available from URL: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed March 2020).
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet 2020; 395: 497-506.
3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with, novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2019; DOI: 10.1001/jama.2020.1585.
4. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
5. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) Situation Summary. Available from URL: https://www.cdc.gov/coronavirus/2019-ncov/summary.html (accessed March 2020).
6. Operations Dashboard for ArcGIS. Available from URL: https://doc.arcgis.com/fr/operations-dashboard (accessed March 2020).
7. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease, (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2019; DOI: 10.1001/jama.2020.2648.
8. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 43. 03 March 2020. Available from URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200303-sitrep-43-covid-19.pdf?sfvrsn=2c21c09c_2 (accessed March 2020).
9. Abdullah Z, Solamat H. Singapore confirms first case of Wuhan virus. CNA. Available from URL: https://www.channelnewsasia.com/news/singapore/wuhan-virus-pneumonia-singapore-confirms-first-case-12312860 (accessed March 2020).
10. Young BE, Ong SW, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020; DOI: 10.1001/jama.2020.3204.
11. Ministry of Health Singapore. Confirmed cases of local transmission of novel coronavirus infection in Singapore. Available from URL: https://www.moh.gov.sg/news-highlights/details/confirmed-cases-of-local-transmission-of-novel-coronavirus-infection-in-singapore (accessed March 2020).
12. Ministry of Health Singapore. Risk assessment raised to DORSCON Orange. 2020. Available from URL: https://www.moh.gov.sg/news-highlights/details/risk-assessment-raised-to-dorscon-orange (accessed March 2020).
13. Wong JE, Leo YS, Tan CC. COVID-19 in Singapore-current experience: critical global issues that require attention and action. JAMA 2020; DOI: 10.1001/jama.2020.2467.
14. World Health Organization. Q&A on coronavirus (COVID-19). Available from URL: https://www.who.int/news-room/q-a-detail/q-a-coronaviruses (accessed March 2020).
15. European Centre for Disease Prevention and Control. COVID-19. Available from URL: https://www.ecdc.europa.eu/en/novel-coronavirus-china (accessed March 2020).
16. Centers for Disease Control and Prevention. Isolation Precautions. Available from URL: https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html (accessed March 2020).
17. Poutanen SM, McGeer AJ. Transmission and control of SARS. Curr Infect Dis Rep 2004; 6: 220-7.
18. Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol 2020; DOI: 10.1016/S2468-1253(20)30048-0.
19. Centers for Disease Control and Prevention. How COVID-19 spreads. Available from URL: https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html (accessed March 2020).
20. Scales DC, Green K, Chan AK, et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003; 9: 1205-10.
21. Loeb M, McGeer A, Henry B, et al. SARS among critical care nurses. Toronto. Emerg Infect Dis 2004; 10: 251-5.
22. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020; DOI: 10.1056/NEJMc2001468.
23. Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan, novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill 2019; DOI: 10.2807/1560-7917.ES.2020.25.4.2000058.
24. Li Q, Guan X, Wu P W, et al. Early Transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 2020; DOI: https://doi.org/10.1056/nejmoa2001316.
25. Kamming D, Gardam M, Chung F. Anaesthesia and SARS. Br J Anaesth 2003; 90: 715-8.
26. Tan TK. How severe acute respiratory syndrome (SARS) affected the department of anaesthesia at Singapore General Hospital. Anaesth Intensive Care 2004; 32: 394-400.
27. Ter Chee VW, Khoo ML, Lee SF, Lai YC, Chin NM. Infection control measures for operative procedures in severe acute respiratory syndrome–related patients. Anesthesiology 2004; 100: 1394-8.
28. World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. WHO guidelines 2007.
29. Ministry of Health Singapore. Additional precautionary measures in response to escalating global situation. Available from URL: https://www.moh.gov.sg/news-highlights/details/additional-precautionary-measures-in-response-to-escalating-global-situation (accessed March 2020).
30. Ti, LK, Ang LS, Foong TW, Ng BS. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anesth 2020; 67. DOI: 10.1007/s12630-020-01617-4.
31. Peng PW, Wong DT, Bevan D, Gardam M. Infection control and anesthesia: lessons learned from the Toronto SARS outbreak. Can J Anesth 2003; 50: 989-97.
32. Christian MD, Loutfy M, McDonald LC, et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004; 10: 287-93.
33. Tompkins BM, Kerchberger JP. Special article: personal protective equipment for care of pandemic influenza patients: a training workshop for the powered air purifying respirator. Anesth Analg 2010; 111: 933-45.
34. Wilkes AR, Benbough JE, Speight SE, Harmer M. The bacterial and viral filtration performance of breathing system filters. Anaesthesia 2000; 55: 458-65.
35. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease, in China. N Engl J Med 2019; DOI: 10.1056/NEJMoa2002032.
36. Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anesth 2020; DOI: 10.1007/s12630-020-01591-x.
37. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; DOI: 10.1016/S0140-6736(20)30360-3.
38. Favre G, Pomar L, Qi X, Nielsen-Saines K, Musso D, Baud D. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis 2020; DOI: 10.1016/S1473-3099(20)30157-2.
39. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). Interim considerations for infection prevention and control of coronavirus disease 2019 (COVID-19) in inpatient obstetric healthcare settings. Available from URL: https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-healthcare-guidance.html (accessed March 2020).
40. Kurup V, Matei V, Ray J. Role of in-situ simulation for training in healthcare: opportunities and challenges. Curr Opin Anaesthesiol 2017; 30: 755-60.
41. Patterson MD, Geis GL, Falcone RA, LeMaster T, Wears RL. In situ simulation: detection of safety threats and teamwork training in a high risk emergency department. BMJ Qual Saf 2013; 22: 468-77.
42. Mastoras G, Poulin C, Norman L, et al. Stress testing the resuscitation room: latent threats to patient safety identified during interprofessional in situ simulation in a Canadian Academic emergency department. AEM Educ Train 2019; DOI: 10.1002/aet2.10422.
43. Fent G, Blythe J, Farooq O, Purva M. In situ simulation as a tool for patient safety: a systematic review identifying how it is used and its effectiveness. BMJ Simul Technol Enhanced Learn 2015; DOI: 10.1136/bmjstel-2015-000065.
44. World Health Organization. Pandemic influenza preparedness and response. A WHO guidance document - 2009. Available from URL: https://apps.who.int/iris/bitstream/handle/10665/44123/9789241547680_eng.pdf;jsessionid=1F82125A878C00D08B9AC204EB320742?sequence=1 (accessed March 2020).
45. Ministry of Health Singapore. MOH pandemic readiness and response plan for influenza and other acute respiratory diseases - April 2014. Available from URL: https://www.moh.gov.sg/docs/librariesprovider5/diseases-updates/interim-pandemic-plan-public-ver-_april-2014.pdf (accessed March 2020).
46. Centers for Disease Control and Prevention. Hierarchy of Controls - NIOSH Workplace Safety and Health Topics. Available from URL: https://www.cdc.gov/niosh/topics/hierarchy/default.html (accessed March 2020).
47. Chen S, Yang J, Yang W, Wang C, Bärnighausen T. COVID-19 control in China during mass population movements at New Year. Lancet 2020; DOI: 10.1016/S0140-6736(20)30421-9.
48. Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MU, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med 2020; DOI: 10.1093/jtm/taaa008.
49. Vaswani K. Coronavirus: why Singapore is so vulnerable to coronavirus spread. BBC News, 13 Feb 2020. Available from URL: https://www.bbc.com/news/world-asia-51480613 (accessed March 2020).
50. Abualenain JT, Al-Alawi MM. Simulation-based training in Ebola personal protective equipment for healthcare workers: experience from King Abdulaziz University Hospital in Saudi Arabia. J Infect Public Health 2018; 11: 796-800.
51. National Academies of Sciences, Engineering, and Medicine. The Ebola Epidemic in West Africa: Proceedings of a Workshop. DC: The National Academies Press; 2016.
52. Lee K, Slavcev A, Nicas M. Respiratory protection against Mycobacterium tuberculosis: quantitative fit test outcomes for five type N95 filtering-facepiece respirators. J Occup Environ Hyg 2004; 1: 22-8.
53. Occupational Safety and Health Administration; US Department of Labor. Assigned protection factors for the revised respiratory protection standard - 2009. Available from URL: https://www.osha.gov/Publications/3352-APF-respirators.pdf (accessed March 2020).
54. Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020; DOI: 10.1016/S2213-2600(20)30066-7.
55. Li JP, Lam DS, Chen Y, Ting DS. Novel coronavirus disease 2019 (COVID-19): the importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol 2020; 104: 297-8.
56. Centers for Disease Control and Prevention. Recommended guidance for extended use and limited reuse of n95 filtering facepiece respirators in healthcare settings - NIOSH Workplace Safety and Health Topic. Available from URL: https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguidanceextuse.html (accessed March 2020).
57. Radonovich LJ Jr, Cheng J, Shenal BV, Hodgson M, Bender BS. Respirator tolerance in health care workers. JAMA 2009; 301: 36-8.
58. Rebmann T, Carrico R, Wang J. Physiologic and other effects and compliance with long-term respirator use among medical intensive care unit nurses. Am J Infect Control 2013; 41: 1218-23.
59. Fisher EM, Shaffer RE. Considerations for recommending extended use and limited reuse of filtering facepiece respirators in health care settings. J Occup Environ Hyg 2014; 11: D115-28.
60. Rebmann T, Alexander S, Bartley J, et al. APIC position paper: extending the use and/or reusing respiratory protection in healthcare settings during disasters. Washington, DC: APIC; 2009.
61. Phan LT, Maita D, Mortiz DC, et al. Personal protective equipment doffing practices of healthcare workers. J Occup Environ Hyg 2019; 16: 575-81.
62. John A, Tomas ME, Cadnum JL, et al. Are health care personnel trained in correct use of personal protective equipment? Am J Infect Control 2016; 44: 840-2.
63. Board on Health Sciences Policy. Institute of Medicine. Defining PAPRs and Current Standards. DC: National Academies Press (US); 2015.
64. Roberge RJ. Evaluation of the rationale for concurrent use of N95 filtering facepiece respirators with loose-fitting powered air-purifying respirators during aerosol-generating medical procedures. Am J Infect Control 2008; 36: 135-41.
65. Coates MJ, Jundi AS, James MR. Chemical protective clothing; a study into the ability of staff to perform lifesaving procedures. J Accid Emerg Med 2000; 17: 115-8.
66. Laird IS, Goldsmith R, Pack RJ, Vitalis A. The effect on heart rate and facial skin temperature of wearing respiratory protection at work. Ann Occup Hyg 2002; 46: 143-8.
67. Nicolle L. SARS safety and science/La science et les mesures de sécurité contre le SRAS. Can J Anesth 2003; DOI: 10.1007/BF03018360.
68. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020; DOI: 10.1016/j.jhin.2020.01.022.
69. Song X, Vossebein L, Zille A. Efficacy of disinfectant-impregnated wipes used for surface disinfection in hospitals: a review. Antimicrob Resist Infect Control 2019; DOI: 10.1186/s13756-019-0595-2.
70. Pottage T, Richardson C, Parks S, Walker JT, Bennett AM. Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses. J Hosp Infect 2010; 74: 55-61.
71. Goyal SM, Chander Y, Yezli S, Otter JA. Evaluating the virucidal efficacy of hydrogen peroxide vapour. J Hosp Infect 2014; 86: 255-9.
72. Kim DK, Kang DH. UVC LED irradiation effectively inactivates aerosolized viruses, bacteria, and fungi in a chamber-type air disinfection system. Appl Environ Microbiol 2018; DOI: 10.1128/AEM.00944-18.